Evidence supporting the use of: Vitamin E (delta-tocotrienol)
For the health condition: Dementia

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Delta-tocotrienol is one of the lesser-known forms of vitamin E, which exists in eight forms (four tocopherols and four tocotrienols). Vitamin E has historically been studied for its antioxidant properties and potential neuroprotective effects. In the context of dementia, especially Alzheimer’s disease, some clinical and preclinical studies have investigated the role of vitamin E supplementation in slowing cognitive decline. Most of the clinical data, however, center on alpha-tocopherol, not delta-tocotrienol. There is scientific rationale for exploring tocotrienols, including delta-tocotrienol, as they demonstrate stronger antioxidant and anti-inflammatory activity in vitro and in animal models compared to tocopherols. Some laboratory and animal studies suggest that tocotrienols may reduce oxidative stress, inhibit neuroinflammation, and protect neuronal cells from amyloid-beta toxicity, mechanisms relevant to dementia pathophysiology. However, robust human clinical trials specifically evaluating delta-tocotrienol for dementia are lacking. A few small studies and reviews suggest tocotrienol-rich fractions may have potential benefits for the brain, but evidence is still preliminary and not conclusive. Overall, while the scientific rationale exists, and there is some preclinical evidence, clinical validation in humans is weak and largely extrapolated from studies on vitamin E in general. Therefore, the evidence supporting delta-tocotrienol’s use in dementia is limited, and it should not be considered a proven therapy.

More about Vitamin E (delta-tocotrienol)
More about Dementia

Products containing Vitamin E (delta-tocotrienol)

We currently have no products on Vitabase that contain this ingredient.